Connection

Guillermo Umpierrez to Humans

Back to Details
This is a "connection" page, showing publications Guillermo Umpierrez has written about Humans.
Guillermo Umpierrez
Connection Strength
0.276
Humans
  1. Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia. J Diabetes Sci Technol. 2021 09; 15(5):1181-1187.
    View in: PubMed
    Score: 0.008
  2. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19. Diabetes Metab Syndr. 2021 Mar-Apr; 15(2):499-503.
    View in: PubMed
    Score: 0.007
  3. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 03; 9(3):174-188.
    View in: PubMed
    Score: 0.007
  4. Hospital Diabetes Meeting 2020. J Diabetes Sci Technol. 2020 09; 14(5):928-944.
    View in: PubMed
    Score: 0.007
  5. Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic. J Diabetes Sci Technol. 2020 Jul; 14(4):705-707.
    View in: PubMed
    Score: 0.007
  6. Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity. Metabolism. 2020 07; 108:154224.
    View in: PubMed
    Score: 0.007
  7. Response to Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579-1589. Diabetes Care. 2019 04; 42(4):e66-e67.
    View in: PubMed
    Score: 0.007
  8. Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide. Diabetes Obes Metab. 2019 06; 21(6):1365-1372.
    View in: PubMed
    Score: 0.007
  9. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY. Endocr Pract. 2019 01; 25(1):69-100.
    View in: PubMed
    Score: 0.006
  10. Response to Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579-1589. Diabetes Care. 2019 01; 42(1):e15.
    View in: PubMed
    Score: 0.006
  11. Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes. Am J Med Sci. 2018 12; 356(6):518-527.
    View in: PubMed
    Score: 0.006
  12. Increasing Hospitalizations for DKA: A Need for Prevention Programs. Diabetes Care. 2018 09; 41(9):1839-1841.
    View in: PubMed
    Score: 0.006
  13. Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study. J Diabetes Complications. 2018 Dec; 32(12):1091-1096.
    View in: PubMed
    Score: 0.006
  14. Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications. Curr Diab Rep. 2018 08 09; 18(9):71.
    View in: PubMed
    Score: 0.006
  15. Global status of diabetes prevention and prospects for action: A consensus statement. Diabetes Metab Res Rev. 2018 09; 34(6):e3021.
    View in: PubMed
    Score: 0.006
  16. THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE. Endocr Pract. 2018 Jun; 24(6):556-564.
    View in: PubMed
    Score: 0.006
  17. Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important? Diabetes Res Clin Pract. 2018 Aug; 142:19-25.
    View in: PubMed
    Score: 0.006
  18. Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients. Endocrinol Metab Clin North Am. 2018 03; 47(1):203-222.
    View in: PubMed
    Score: 0.006
  19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS. Endocr Pract. 2018 Mar; 24(3):302-308.
    View in: PubMed
    Score: 0.006
  20. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY. Endocr Pract. 2018 01; 24(1):91-120.
    View in: PubMed
    Score: 0.006
  21. A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial. J Am Med Dir Assoc. 2018 05; 19(5):399-404.e3.
    View in: PubMed
    Score: 0.006
  22. Diabetes and Atherosclerotic Cardiovascular Disease: Novel Insights and Therapeutic Strategies. Endocrinol Metab Clin North Am. 2018 03; 47(1):xv-xvi.
    View in: PubMed
    Score: 0.006
  23. Stress hyperglycemia in general surgery: Why should we care? J Diabetes Complications. 2018 03; 32(3):305-309.
    View in: PubMed
    Score: 0.006
  24. AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES. Endocr Pract. 2017 Nov; 23(11):1345-1349.
    View in: PubMed
    Score: 0.006
  25. Management of Type 1 Diabetes in the Hospital Setting. Curr Diab Rep. 2017 09 14; 17(10):98.
    View in: PubMed
    Score: 0.006
  26. Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies. J Diabetes. 2018 Feb; 10(2):94-111.
    View in: PubMed
    Score: 0.006
  27. COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES. Endocr Pract. 2017 Sep; 23(9):1059-1066.
    View in: PubMed
    Score: 0.006
  28. Diabetes: SGLT2 inhibitors and diabetic ketoacidosis - a growing concern. Nat Rev Endocrinol. 2017 08; 13(8):441-442.
    View in: PubMed
    Score: 0.006
  29. DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES. Endocr Pract. 2017 Aug; 23(8):971-978.
    View in: PubMed
    Score: 0.006
  30. Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes. Diabetes Obes Metab. 2017 09; 19(9):1317-1321.
    View in: PubMed
    Score: 0.006
  31. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am. 2017 May; 101(3):587-606.
    View in: PubMed
    Score: 0.006
  32. Management of Inpatient Hyperglycemia and Diabetes in Older Adults. Diabetes Care. 2017 Apr; 40(4):509-517.
    View in: PubMed
    Score: 0.006
  33. Guidelines for management of diabetic ketoacidosis: time to revise? Lancet Diabetes Endocrinol. 2017 05; 5(5):321-323.
    View in: PubMed
    Score: 0.006
  34. Perioperative Hyperglycemia Management: An Update. Anesthesiology. 2017 03; 126(3):547-560.
    View in: PubMed
    Score: 0.006
  35. PERSPECTIVES ON LEARNING AND CLINICAL PRACTICE IMPROVEMENT FOR DIABETES IN THE HOSPITAL: A REVIEW OF EDUCATIONAL INTERVENTIONS FOR PROVIDERS. Endocr Pract. 2017 05; 23(5):614-626.
    View in: PubMed
    Score: 0.006
  36. Social vulnerability and hypoglycemia among patients with diabetes. Endocrinol Diabetes Nutr. 2017 Feb; 64(2):92-99.
    View in: PubMed
    Score: 0.006
  37. Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy. J Diabetes Complications. 2017 Apr; 31(4):742-747.
    View in: PubMed
    Score: 0.006
  38. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. Endocr Pract. 2017 02; 23(2):207-238.
    View in: PubMed
    Score: 0.006
  39. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes. J Clin Anesth. 2017 Feb; 36:184-188.
    View in: PubMed
    Score: 0.006
  40. Randomized Controlled Study of Metformin and Sitagliptin on Long-term Normoglycemia Remission in African American Patients With Hyperglycemic Crises. Diabetes Care. 2016 Nov; 39(11):1948-1955.
    View in: PubMed
    Score: 0.005
  41. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016 Apr; 12(4):222-32.
    View in: PubMed
    Score: 0.005
  42. Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes. Diabetes Care. 2010 Mar; 33(3):626-31.
    View in: PubMed
    Score: 0.003
  43. Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19. JAMA Netw Open. 2021 03 01; 4(3):e211091.
    View in: PubMed
    Score: 0.002
  44. Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept. Diabetes Care. 2021 04; 44(4):1055-1058.
    View in: PubMed
    Score: 0.002
  45. Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic. Diabetes Care. 2021 03; 44(3):847-849.
    View in: PubMed
    Score: 0.002
  46. Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis. Diabetes Care. 2021 02; 44(2):578-585.
    View in: PubMed
    Score: 0.002
  47. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. J Diabetes Sci Technol. 2020 11; 14(6):1035-1064.
    View in: PubMed
    Score: 0.002
  48. Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. J Diabetes Sci Technol. 2020 Jul; 14(4):822-832.
    View in: PubMed
    Score: 0.002
  49. Association of Glucose Concentrations at Hospital Discharge With Readmissions and Mortality: A Nationwide Cohort Study. J Clin Endocrinol Metab. 2019 09 01; 104(9):3679-3691.
    View in: PubMed
    Score: 0.002
  50. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial. Diabetes Obes Metab. 2019 04; 21(4):837-843.
    View in: PubMed
    Score: 0.002
  51. Dietary Behaviors and Glucose Metabolism in Young Adults at Risk for Type 2 Diabetes. Diabetes Educ. 2018 04; 44(2):158-167.
    View in: PubMed
    Score: 0.002
  52. The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System. J Diabetes Sci Technol. 2018 01; 12(1):20-25.
    View in: PubMed
    Score: 0.001
  53. Glucose Control, Diabetes Status, and Mortality in Critically Ill Patients: The Continuum From Intensive Care Unit Admission to Hospital Discharge. Mayo Clin Proc. 2017 07; 92(7):1019-1029.
    View in: PubMed
    Score: 0.001
  54. Consensus Statement on Inpatient Use of Continuous Glucose Monitoring. J Diabetes Sci Technol. 2017 09; 11(5):1036-1044.
    View in: PubMed
    Score: 0.001
  55. A feasibility study to develop a diabetes prevention program for young adults with prediabetes by using digital platforms and a handheld device. Diabetes Educ. 2014 Sep-Oct; 40(5):626-37.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.